Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

  Alzheimer's Disease

  Free Subscription


Articles published in Curr Alzheimer Res

Retrieve available abstracts of 260 articles:
HTML format
Text format



Single Articles


    July 2018
  1. KAPOGIANNIS D, El Haj M
    Beneficial effect of minimal interference on item memory but not on source memory in Alzheimer's disease.
    Curr Alzheimer Res. 2018 Jul 10. pii: CAR-EPUB-91624.
    PubMed     Text format     Abstract available


  2. LAZZARI C
    Ecological Momentary Assessments and Interventions in Alzheimer's Caregiving.
    Curr Alzheimer Res. 2018 Jul 1. pii: CAR-EPUB-91415.
    PubMed     Text format     Abstract available


    June 2018
  3. RUFFINATTI F, Tapella L, Gregnanin I, Stevano A, et al
    Transcriptional remodeling in primary hippocampal astrocytes from an Alzheimer's disease mouse model.
    Curr Alzheimer Res. 2018 Jun 12. pii: CAR-EPUB-91108.
    PubMed     Text format     Abstract available


  4. BLESA R, Toriyama K, Ueda K, Knox S, et al
    Strategies for Continued Successful Treatment in Patients with Alzheimer's Disease: An Overview of Switching Between Pharmacological Agents.
    Curr Alzheimer Res. 2018 Jun 12. pii: CAR-EPUB-91107.
    PubMed     Text format     Abstract available


  5. WEE M, Chegini F, Power JHT, Majd S, et al
    Tau Positive Neurons Show Marked Mitochondrial Loss and Nuclear Degradation in Alzheimer's Disease.
    Curr Alzheimer Res. 2018 Jun 12. pii: CAR-EPUB-91110.
    PubMed     Text format     Abstract available


  6. EZIO G, Giancarlo P
    Sex and Gender Differences in the Brain Cholinergic System and in the Response to Therapy of Alzheimer Disease with Cholinesterase Inhibitors.
    Curr Alzheimer Res. 2018 Jun 12. pii: CAR-EPUB-91106.
    PubMed     Text format     Abstract available


    May 2018
  7. ZVEROVA M, Kitzlerova E, Fisar Z, Jirak R, et al
    Interplay between the APOE genotype and possible plasma biomarkers in Alzheimer's disease.
    Curr Alzheimer Res. 2018 May 31. pii: CAR-EPUB-90848.
    PubMed     Text format     Abstract available


  8. WAN L, Lu J, Fu J, Huang J, et al
    Acetylcholinesterase inhibitor donepezil effects on plasma beta-hydroxybutyrate levels in the treatment of Alzheimer's disease.
    Curr Alzheimer Res. 2018 May 31. pii: CAR-EPUB-90849.
    PubMed     Text format     Abstract available


  9. WATTMO C, Londos E, Minthon L
    Short-Term Response to Cholinesterase Inhibitors in Alzheimer's Disease Delays Time to Nursing Home Placement.
    Curr Alzheimer Res. 2018 May 6. pii: CAR-EPUB-90210.
    PubMed     Text format     Abstract available


    April 2018
  10. RUAN Y, Tang J, Guo X, Li K, et al
    Dietary Fat Intake and Risk of Alzheimer's Disease and Dementia: A Meta-Analysis of Cohort Studies.
    Curr Alzheimer Res. 2018 Apr 27. pii: CAR-EPUB-90033.
    PubMed     Text format     Abstract available


  11. MARESOVA P, Tomsone S, Lameski P, Madureira J, et al
    Technological Solutions for Older People with Alzheimer's Disease: Review.
    Curr Alzheimer Res. 2018 Apr 27. pii: CAR-EPUB-90032.
    PubMed     Text format     Abstract available


  12. PATTEN RV, Fagan AM, Kaufman DAS
    Differential Cued-Stroop Performance in Cognitively Asymptomatic Older Adults with Biomarker-Identified Risk for Alzheimer's Disease: A Pilot Study.
    Curr Alzheimer Res. 2018 Apr 4. pii: CAR-EPUB-89533.
    PubMed     Text format     Abstract available


  13. MUKAETOVA-LADINSKA EB, Abdell-All Z, Andrade J, da Silva JA, et al
    Platelet tau protein as a potential peripheral biomarker in Alzheimer's disease: An explorative study.
    Curr Alzheimer Res. 2018 Apr 4. pii: CAR-EPUB-89532.
    PubMed     Text format     Abstract available


  14. DE LOOZE C, Kelly F, Crosby L, Vourdanou A, et al
    Changes in Speech Chunking in Reading Aloud is a marker of Mild Cognitive Impairment and Mild-to-Moderate Alzheimer's Disease.
    Curr Alzheimer Res. 2018 Apr 4. pii: CAR-EPUB-89531.
    PubMed     Text format     Abstract available


  15. LIU SY, Lu S, Yu XL, Yang SG, et al
    Fruitless wolfberry-sprout extract rescued cognitive deficits and attenuated neuropathology in Alzheimer's disease transgenic mice.
    Curr Alzheimer Res. 2018 Apr 4. pii: CAR-EPUB-89527.
    PubMed     Text format     Abstract available


  16. BATURE F, Pang D, Robinson A, Polson N, et al
    Identifying patterns in signs and symptoms preceding the clinical diagnosis of Alzheimer's disease: Retrospective medical record review study and a nested case -control design.
    Curr Alzheimer Res. 2018 Apr 4. pii: CAR-EPUB-89525.
    PubMed     Text format     Abstract available


    February 2018
  17. MAJD S, Power JHT
    Oxidative Stress and Decreased Mitochondrial Superoxide Dismutase 2 and Peroxiredoxin 1 and 4 Based Mechanism of Concurrent Activation of AMPK and mTOR in Alzheimer's disease.
    Curr Alzheimer Res. 2018 Feb 22. pii: CAR-EPUB-88760.
    PubMed     Text format     Abstract available


  18. MORENO S
    Editorial: Signaling Molecules as Biomarkers and Therapeutic Targets for Alzheimer's Disease: A New Perspective.
    Curr Alzheimer Res. 2018;15:302.
    PubMed     Text format    


  19. MARTINEZ-TORTEYA A, Gomez-Rueda H, Trevino V, Farber J, et al
    Identification and Temporal Characterization of Features Associated with the Conversion from Mild Cognitive Impairment to Alzheimer's Disease.
    Curr Alzheimer Res. 2018 Feb 1. pii: CAR-EPUB-88334.
    PubMed     Text format     Abstract available


    January 2018
  20. UKALOVIC K, Cao S, Lee S, Tang Q, et al
    Drusen in the Peripheral Retina of the Alzheimer's Eye.
    Curr Alzheimer Res. 2018 Jan 23. pii: CAR-EPUB-88136.
    PubMed     Text format     Abstract available


  21. SANCESARIO GM, Nuccetelli M, Cerri A, Zegeer J, et al
    Bromelain degrades Abeta1-42 monomers and soluble aggregates: an in vitro study in cerebrospinal fluid of Alzheimer's disease patients.
    Curr Alzheimer Res. 2018 Jan 23. pii: CAR-EPUB-88138.
    PubMed     Text format     Abstract available


  22. MORRISON C, Rabipour S, Knoefel F, Shepard C, et al
    Auditory Event-Related Potentials in Mild Cognitive Impairment and Alzheimer's disease: A Literature Review.
    Curr Alzheimer Res. 2018 Jan 23. pii: CAR-EPUB-88137.
    PubMed     Text format     Abstract available


  23. DAVIS M, O Connell T, Johnson S, Cline S, et al
    Estimating Alzheimer's disease progression rates from normal cognition through mild cognitive impairment and stages of dementia.
    Curr Alzheimer Res. 2018 Jan 18. pii: CAR-EPUB-88040.
    PubMed     Text format     Abstract available


  24. ZHANG H, Liu D, Huang H, Zhao Y, et al
    Characteristics of Insulin-degrading Enzyme in Alzheimer's Disease: A Meta-analysis.
    Curr Alzheimer Res. 2018 Jan 18. pii: CAR-EPUB-88046.
    PubMed     Text format     Abstract available


  25. BECKER RE, Greig NH, Lahiri DK, Bledsoe J, et al
    (-)-Phenserine and Inhibiting Pre-Programmed Cell Death: In Pursuit of a Novel Intervention for Alzheimer's Disease.
    Curr Alzheimer Res. 2018 Jan 10. pii: CAR-EPUB-87805.
    PubMed     Text format     Abstract available


  26. VERCRUYSSE O, Paquet C, Gabelle A, Delbeuck X, et al
    Relevance of Follow-Up in Patients with Core Clinical Criteria for Alzheimer Disease and Normal CSF biomarkers.
    Curr Alzheimer Res. 2018 Jan 9. pii: CAR-EPUB-87803.
    PubMed     Text format     Abstract available


    December 2017
  27. KUCHTOVA B, Wurst Z, Mrzilkova J, Ibrahim I, et al
    Compensatory shift of subcallosal area and paraterminal gyrus white matter parameters on DTI in patients with Alzheimer disease.
    Curr Alzheimer Res. 2017 Dec 27. pii: CAR-EPUB-87574.
    PubMed     Text format     Abstract available


  28. SANZ-BLASCO S, Calvo-Rodriguez M, Caballero E, Garcia-Durillo M, et al
    Is it all said for NSAIDs in Alzheimer's disease? Role of mitochondrial calcium uptake.
    Curr Alzheimer Res. 2017 Dec 27. pii: CAR-EPUB-87572.
    PubMed     Text format     Abstract available


  29. PERKOVIC MN, Strac DS, Tudor L, Konjevod M, et al
    Catechol-O-methyltransferase, cognition and Alzheimer's disease.
    Curr Alzheimer Res. 2017 Dec 11. pii: CAR-EPUB-87350.
    PubMed     Text format     Abstract available


    November 2017
  30. LOPEZ-DE-IPINA K, Martinez-de-Lizarduy U, Calvo PM, Mekyska J, et al
    Advances on Automatic Speech Analysis for Early Detection of Alzheimer Disease: a Non-linear Multi-task Approach.
    Curr Alzheimer Res. 2017 Nov 20. doi: 10.2174/1567205014666171120143800.
    PubMed     Text format     Abstract available


  31. JIRI C, Ross A, Jan L, Martin V, et al
    Subjective Spatial Navigation Complaints - A Frequent Symptom Reported by Patients with Subjective Cognitive Decline, Mild Cognitive Impairment and Alzheimer's Disease.
    Curr Alzheimer Res. 2017 Nov 20. doi: 10.2174/1567205014666171120145349.
    PubMed     Text format     Abstract available


  32. KATO S, Homma A, Sakuma T
    Easy Screening for Mild Alzheimer's Disease and Mild Cognitive Impairment from Elderly Speech.
    Curr Alzheimer Res. 2017 Nov 20. doi: 10.2174/1567205014666171120144343.
    PubMed     Text format     Abstract available


  33. TREBBASTONI A, Imbriano L, Podda L, Rendace L, et al
    Cognitive training in patients with Alzheimer's disease: findings of a 12-month randomized controlled trial.
    Curr Alzheimer Res. 2017 Nov 12. doi: 10.2174/1567205014666171113105044.
    PubMed     Text format     Abstract available


  34. QIU WY, Yang Q, Zhang W, Wang N, et al
    The Correlations Between Postmortem Brain Pathologies and Cognitive Dysfunction in Aging and Alzheimer's Disease.
    Curr Alzheimer Res. 2017 Nov 6. doi: 10.2174/1567205014666171106150915.
    PubMed     Text format     Abstract available


  35. VERMA N, Beretvas SN, Pascual B, Masdeu JC, et al
    A biomarker combining imaging and neuropsychological assessment for tracking early Alzheimer's disease in clinical trials.
    Curr Alzheimer Res. 2017 Nov 6. doi: 10.2174/1567205014666171106150309.
    PubMed     Text format     Abstract available


    October 2017
  36. RUGGIERO G, Iavarone A, Iachini T
    Allocentric to Egocentric Spatial Switching: Impairment in aMCI and Alzheimer's Disease Patients?
    Curr Alzheimer Res. 2017 Oct 30. doi: 10.2174/1567205014666171030114821.
    PubMed     Text format     Abstract available


  37. XAVIER C, Justine B, Laurent O, Isabelle L, et al
    Body-centred and object-centred motor imagery in Alzheimer disease.
    Curr Alzheimer Res. 2017 Oct 29. doi: 10.2174/1567205014666171030105720.
    PubMed     Text format     Abstract available


  38. DE OLIVEIRA FF, Chen ES, Smith MC, Bertolucci PHF, et al
    Pharmacogenetics of angiotensin-converting enzyme inhibitors in patients with Alzheimer's disease dementia.
    Curr Alzheimer Res. 2017 Oct 16. doi: 10.2174/1567205014666171016101816.
    PubMed     Text format     Abstract available


  39. SUNG PS, Wu MN, Chou PS, Su HC, et al
    Longitudinal Neuropsychological Outcome in Taiwanese Alzheimer's Disease patients treated with medication.
    Curr Alzheimer Res. 2017 Oct 10. doi: 10.2174/1567205014666171010112518.
    PubMed     Text format     Abstract available


    September 2017
  40. MANYEVITCH R, Protas M, Scarpiello S, Deliso M, et al
    Evaluation Of Metabolic And Synaptic Dysfunction Hypotheses Of Alzheimer's Disease (Ad): A Meta-Analysis Of Csf Markers.
    Curr Alzheimer Res. 2017 Sep 21. doi: 10.2174/1567205014666170921122458.
    PubMed     Text format     Abstract available


  41. ORTIZ A, Lozano F, Gorriz JM, Ramirez J, et al
    Discriminative Sparse Features for Alzheimer's Disease Diagnosis using multimodal image data.
    Curr Alzheimer Res. 2017 Sep 21. doi: 10.2174/1567205014666170922101135.
    PubMed     Text format     Abstract available


  42. ERDMANN P, Langanke M
    The Ambivalence of Early Diagnosis - Returning results in current Alzheimer research.
    Curr Alzheimer Res. 2017 Sep 7. doi: 10.2174/1567205014666170908101237.
    PubMed     Text format     Abstract available


    August 2017
  43. BUSINARO R, Di Raimo T, Corsi M, Asprino R, et al
    Modulation Of Inflammation As A Way Of Delaying Alzheimer's Disease Progression: The Diet's Role.
    Curr Alzheimer Res. 2017 Aug 28. doi: 10.2174/1567205014666170829100100.
    PubMed     Text format     Abstract available


  44. GUPTA P, Bhattacharjee S, Sharma AR, Sharma G, et al
    miRNAs in Alzheimer disease - a Therapeutic perspective.
    Curr Alzheimer Res. 2017 Aug 28. doi: 10.2174/1567205014666170829101016.
    PubMed     Text format     Abstract available


  45. QIAN W, Fischer CE, Schweizer TA, Munoz DG, et al
    Association between psychosis phenotype and APOE genotype on the clinical profiles of Alzheimer's disease.
    Curr Alzheimer Res. 2017 Aug 28. doi: 10.2174/1567205014666170829114346.
    PubMed     Text format     Abstract available


  46. MEILAN JJG, Martinez-Sanchez F, Carro J, Carcavilla N, et al
    Voice Markers of Lexical Access in Mild Cognitive Impairment and Alzheimer's Disease.
    Curr Alzheimer Res. 2017 Aug 28. doi: 10.2174/1567205014666170829112439.
    PubMed     Text format     Abstract available


  47. LO VASCO VR
    The Phosphoinositide signal transduction pathway in the pathogenesis of Alzheimer's Disease.
    Curr Alzheimer Res. 2017 Aug 28. doi: 10.2174/1567205014666170829100230.
    PubMed     Text format     Abstract available


    July 2017
  48. LI N, Hu P, Xu T, Chen H, et al
    iTRAQ-based proteomic analysis of APPSw,Ind mice provides insights into the early changes in Alzheimer's disease.
    Curr Alzheimer Res. 2017 Jul 19. doi: 10.2174/1567205014666170719165745.
    PubMed     Text format     Abstract available


  49. FUKASAWA JT, Labio RW, Rasmussen LT, Oliveira LC, et al
    CDK5 and MAPT Gene Expression in Alzheimer's Disease Brain Samples.
    Curr Alzheimer Res. 2017 Jul 13. doi: 10.2174/1567205014666170713160407.
    PubMed     Text format     Abstract available


  50. ARENA A, Iyer AM, Milenkovic I, Kovacs GG, et al
    Developmental expression and dysregulation of miR-146a and miR-155 in Down's syndrome and mouse models of Down's syndrome and Alzheimer's disease.
    Curr Alzheimer Res. 2017 Jul 6. doi: 10.2174/1567205014666170706112701.
    PubMed     Text format     Abstract available


    June 2017
  51. SQUITT R, Simonelli I, Cassetta E, Lupoi D, et al
    Patients with increased non-ceruloplasmin copper appear a distinct sub-group of alzheimer's disease: a neuroimaging study.
    Curr Alzheimer Res. 2017 Jun 23. doi: 10.2174/1567205014666170623125156.
    PubMed     Text format     Abstract available


  52. KOLOSOVA NG, Tyumentsev MA, Muraleva NA, Kiseleva E, et al
    Antioxidant SkQ1 Alleviates Signs of Alzheimer's Disease-like Pathology in Old OXYS Rats by Reversing Mitochondrial Deterioration.
    Curr Alzheimer Res. 2017 Jun 21. doi: 10.2174/1567205014666170621111033.
    PubMed     Text format     Abstract available


  53. PARRA MA, Mikulan E, Trujillo N, Sala SD, et al
    Brain information sharing during visual short-term memory binding yields a memory biomarker for familial Alzheimer's disease.
    Curr Alzheimer Res. 2017 Jun 14. doi: 10.2174/1567205014666170614163316.
    PubMed     Text format     Abstract available


    May 2017
  54. SILVA AR, Pinho MS, Macedo L, Moulin CJA, et al
    The cognitive effects of wearable cameras in Mild Alzheimer disease - An experimental study.
    Curr Alzheimer Res. 2017 May 30. doi: 10.2174/1567205014666170531083015.
    PubMed     Text format     Abstract available


  55. WAMS EJ, Wilcock GK, Foster RG, Wulff K, et al
    Sleep-wake patterns and cognition of older adults with amnestic mild cognitive impairment (aMCI): A comparison with cognitively healthy adults and moderate Alzheimer's disease patients.
    Curr Alzheimer Res. 2017 May 22. doi: 10.2174/1567205014666170523095634.
    PubMed     Text format     Abstract available


  56. AHMAD J, Akhter S, Rizwanullah M, Khan MA, et al
    Nanotechnology based theranostic approaches in Alzheimer's disease management: Current status and future perspective.
    Curr Alzheimer Res. 2017 May 8. doi: 10.2174/1567205014666170508121031.
    PubMed     Text format     Abstract available


  57. D ORIO B, Fracassi A, Ceru MP, Moreno S, et al
    Targeting Pparalpha In Alzheimer`s Disease.
    Curr Alzheimer Res. 2017 May 4. doi: 10.2174/1567205014666170505094549.
    PubMed     Text format     Abstract available


  58. MARCELLI S, Corbo M, Iannuzzi F, Negri L, et al
    The Involvement of Post-Translational Modifications in Alzheimer's Disease.
    Curr Alzheimer Res. 2017 May 4. doi: 10.2174/1567205014666170505095109.
    PubMed     Text format     Abstract available


  59. ZARROUK A, Debbabi M, Bezine M, Karym EM, et al
    Lipid Biomarkers in Alzheimer's Disease.
    Curr Alzheimer Res. 2017 May 4. doi: 10.2174/1567205014666170505101426.
    PubMed     Text format     Abstract available


  60. ARMAND-UGON M, Ansoleaga B, Berjaoui S, Ferrer I, et al
    Reduced mitochondrial activity is early and steady in the entorhinal cortex but it is mainly unmodified in the frontal cortex in Alzheimer's disease.
    Curr Alzheimer Res. 2017 May 4. doi: 10.2174/1567205014666170505095921.
    PubMed     Text format     Abstract available


    April 2017
  61. ALAMEDA-BAILEN JR, Salguero-Alcaniz MP, Merchan-Clavellino A, Paino-Quesada S, et al
    Cognitive Mechanisms In Decision-Making In Patients With Mild Alzheimer Disease.
    Curr Alzheimer Res. 2017 Apr 17. doi: 10.2174/1567205014666170417113834.
    PubMed     Text format     Abstract available


  62. HE J, Liao T, Zhong GX, Zhang JD, et al
    Alzheimer`s disease-like early-phase brain pathogenesis: Self-curing amelioration of neurodegeneration from pro-inflammatory 'wounding' to anti-inflammatory 'healing'.
    Curr Alzheimer Res. 2017 Apr 17. doi: 10.2174/1567205014666170417111420.
    PubMed     Text format     Abstract available


  63. GAO Y, Tan L, Yu JT, Tan L, et al
    Tau in Alzheimer's disease: Mechanisms and therapeutic strategies.
    Curr Alzheimer Res. 2017 Apr 17. doi: 10.2174/1567205014666170417111859.
    PubMed     Text format     Abstract available


  64. KOJIMA G, Liljas A, Iliffe S, Walters K, et al
    Prevalence of Frailty in Mild to Moderate Alzheimer's Disease: A Systematic Review and Meta-analysis.
    Curr Alzheimer Res. 2017 Apr 17. doi: 10.2174/1567205014666170417104236.
    PubMed     Text format     Abstract available


  65. VERITE J, Janet T, Julian A, Chassaing D, et al
    Peripheral blood mononuclear cells of Alzheimer's disease patients control CCL4 and CXCL10 levels in a human blood brain barrier model.
    Curr Alzheimer Res. 2017 Apr 17. doi: 10.2174/1567205014666170417110337.
    PubMed     Text format     Abstract available


    March 2017
  66. SHARIFLOU S, Georgevsky D, Mansour H, Rezaeian M, et al
    Diagnostic and prognostic potential of retinal biomarkers in early on-set Alzheimer`s disease.
    Curr Alzheimer Res. 2017 Mar 29. doi: 10.2174/1567205014666170329114445.
    PubMed     Text format     Abstract available


  67. ECHEVERRIA V, Barreto GE, Avila-Rodriguez M, Tarasov VV, et al
    Is VEGF a key target of cotinine and other potential therapies against Alzheimer disease?
    Curr Alzheimer Res. 2017 Mar 29. doi: 10.2174/1567205014666170329113007.
    PubMed     Text format     Abstract available


  68. DOMINGUES C, da Cruz E Silva OA, Henriques AG
    Impact of Cytokines and Chemokines on Alzheimer's Disease Neuropathological Hallmarks.
    Curr Alzheimer Res. 2017 Mar 17. doi: 10.2174/1567205014666170317113606.
    PubMed     Text format     Abstract available


  69. RODRIGUEZ-CASADO A, Toledano-Diaz A, Toledano A
    Defective Insulin Signalling, Mediated by Inflammation, Connects Obesity to Alzheimer Disease; Relevant Pharmacological Therapies and Preventive Dietary Interventions.
    Curr Alzheimer Res. 2017 Mar 16. doi: 10.2174/1567205014666170316161848.
    PubMed     Text format     Abstract available


  70. POZA J, Gomez C, Garcia M, Tola-Arribas MA, et al
    Spatio-Temporal Fluctuations of Neural Dynamics in Mild Cognitive Impairment and Alzheimer's Disease.
    Curr Alzheimer Res. 2017 Mar 9. doi: 10.2174/1567205014666170309115656.
    PubMed     Text format     Abstract available


  71. GARRE-OLMO J, Faundez-Zanuy M, Lopez-de-Ipina K, Calvo-Perxas L, et al
    Kinematic and pressure features of handwriting and drawing: preliminary results between patients with mild cognitive impairment, Alzheimer disease and healthy controls.
    Curr Alzheimer Res. 2017 Mar 9. doi: 10.2174/1567205014666170309120708.
    PubMed     Text format     Abstract available


  72. GARRARD P, Nemes V, Nikolic D, Barney A, et al
    Motif discovery in speech: Application to monitoring Alzheimer's disease.
    Curr Alzheimer Res. 2017 Mar 9. doi: 10.2174/1567205014666170309121025.
    PubMed     Text format     Abstract available


    February 2017
  73. SHARMA S, Lipincott W
    Biomarkers in Alzheimer's Disease-Recent Update.
    Curr Alzheimer Res. 2017 Feb 20. doi: 10.2174/1567205014666170220141822.
    PubMed     Text format     Abstract available


  74. KIM J, Fischer CE, Schweizer TA, Munoz DG, et al
    Gender and Pathology-Specific Effect of Apolipoprotein E Genotype on Psychosis in Alzheimer's Disease.
    Curr Alzheimer Res. 2017 Feb 20. doi: 10.2174/1567205014666170220150021.
    PubMed     Text format     Abstract available


  75. NIXON DW
    The Inverse Relationship Between Cancer and Alzheimer's Disease: A Possible Mechanism.
    Curr Alzheimer Res. 2017 Feb 16. doi: 10.2174/1567205014666170216152905.
    PubMed     Text format     Abstract available


  76. DE MARCO M, Vallelunga A, Meneghello F, Varma S, et al
    ApoE epsilon4 allele relateted alterations in hippocampal connectivity in early Alzheimer's disease support memory performance.
    Curr Alzheimer Res. 2017 Feb 6. doi: 10.2174/1567205014666170206113528.
    PubMed     Text format     Abstract available


  77. WU W, Xie S, Li B, Yang K, et al
    Protective effects of Huang-Lian-Jie-Du-Tang on Abeta25-35-induced memory deficits and oxidative stress in male rats.
    Curr Alzheimer Res. 2017 Feb 6. doi: 10.2174/1567205014666170206163158.
    PubMed     Text format     Abstract available


  78. NICOLIA V, Ciraci V, Cavallaro RA, Ferrer I, et al
    GSK3beta 5'-flanking DNA methylation and expression in Alzheimer's Disease patients.
    Curr Alzheimer Res. 2017 Feb 3. doi: 10.2174/1567205014666170203153325.
    PubMed     Text format     Abstract available


  79. LESZEK J, Tse WH, Zhang J, Avila-Rodriguez MF, et al
    Nanotechnology for Alzheimer Disease.
    Curr Alzheimer Res. 2017 Feb 3. doi: 10.2174/1567205014666170203125008.
    PubMed     Text format     Abstract available


  80. MANTZAVINOSA V, Alexiou A, Greig NH, Kamal MA, et al
    Biomarkers for Alzheimer's Disease Diagnosis.
    Curr Alzheimer Res. 2017 Feb 3. doi: 10.2174/1567205014666170203125942.
    PubMed     Text format     Abstract available


  81. AHMAD K, Baig MH, Mushtaq G, Kamal MA, et al
    Commonalities in biological pathways, genetics, and cellular mechanism between Alzheimer Disease and other neurodegenerative diseases: An in silico-updated overview.
    Curr Alzheimer Res. 2017 Feb 3. doi: 10.2174/1567205014666170203141151.
    PubMed     Text format     Abstract available


  82. REGEN F, Hellmann-Regen J, Costantini E, Reale M, et al
    Neuroinflammation and Alzheimer's Disease: Implications for Microglial Activation.
    Curr Alzheimer Res. 2017 Feb 3. doi: 10.2174/1567205014666170203141717.
    PubMed     Text format     Abstract available


  83. SHACKLETON B, Crawford F, Bachmeier C
    Apolipoprotein E-mediated modulation of ADAM10 in Alzheimer's disease.
    Curr Alzheimer Res. 2017 Feb 2. doi: 10.2174/1567205014666170203093219.
    PubMed     Text format     Abstract available


  84. CHHETRI J, King AE, Gueven N
    Alzheimer's Disease and NQO1: Is there a Link?
    Curr Alzheimer Res. 2017 Feb 2. doi: 10.2174/1567205014666170203095802.
    PubMed     Text format     Abstract available


  85. COSTA IB, Labio RW, Rasmussen LT, Viani GA, et al
    Change in INSR, APBA2 and IDE Gene Expressions in Brains of Alzheimer s Disease Patients.
    Curr Alzheimer Res. 2017 Feb 2. doi: 10.2174/1567205014666170203100734.
    PubMed     Text format     Abstract available


    January 2017
  86. DECOURT B, Drumm-Gurnee D, Wilson J, Jacobson S, et al
    Poor Safety and Tolerability Hamper Reaching a Potentially Therapeutic Dose in the Use of Thalidomide for Alzheimer's disease: Results from a Double-Blind, Placebo-Controlled Trial.
    Curr Alzheimer Res. 2017.
    PubMed     Text format     Abstract available


  87. FUKAMI Y, Ariga T, Yamada M, Yuki N, et al
    Brain gangliosides in Alzheimer's disease: Increased expression of cholinergic neuron-specific gangliosides.
    Curr Alzheimer Res. 2017.
    PubMed     Text format     Abstract available


  88. HULL M, Sadowsky C, Arai H, Le Prince Leterme G, et al
    Long-Term Extensions of Randomized Vaccination Trials of ACC-001 and QS-21 in Mild to Moderate Alzheimer's Disease.
    Curr Alzheimer Res. 2017.
    PubMed     Text format     Abstract available


  89. TERZIOGLU-USAK S, Negis Y, Karabulut DS, Zaim M, et al
    Cellular model of Alzheimer's disease: Abeta1-42 peptide induces amyloid deposition and a decrease in topo isomerase IIbeta and Nurr1 expression.
    Curr Alzheimer Res. 2017.
    PubMed     Text format     Abstract available


  90. KLIMOVA B, Kuca K
    Alzheimer's Disease and Chinese Medicine as a Useful Alternative Intervention Tool: A Mini-Review Alzheimer's Disease and Chinese Medicine.
    Curr Alzheimer Res. 2017.
    PubMed     Text format     Abstract available


  91. ANNA P, Federico S, Massimo V
    Resilience to Alzheimer's disease: the role of physical activity.
    Curr Alzheimer Res. 2017.
    PubMed     Text format     Abstract available


  92. KRANTIC S
    Editorial: From Current Diagnostic Tools and Therapeutics for Alzheimer's Disease Towards Earlier Diagnostic Markers and Treatment Targets.
    Curr Alzheimer Res. 2017;14:2-5.
    PubMed     Text format    


  93. LOPEZ-DE-IPINA K, Laske C
    Editorial:Advanced Methods of Biomedical Signal Processing for Early Detection of Alzheimer's Disease.
    Curr Alzheimer Res. 2017;14:914-915.
    PubMed     Text format    


  94. SANCHEZ-CATASUS CA, Stormezand GN, van Laar PJ, De Deyn PP, et al
    FDG-PET for Prediction of AD Dementia in Mild Cognitive Impairment. A Review of the State of the Art with Particular Emphasis on the Comparison with Other Neuroimaging Modalities (MRI and Perfusion SPECT).
    Curr Alzheimer Res. 2017;14:127-142.
    PubMed     Text format     Abstract available


  95. KAMAL MA, Greig NH
    Editorial: Alzheimer's Disease: From Molecular Mechanisms to Psychobiological Perspectives.
    Curr Alzheimer Res. 2017;14:1138-1139.
    PubMed     Text format    


  96. PERCHE F, Uchida S, Akiba H, Lin CY, et al
    Improved Brain Expression of Anti-Amyloid beta scFv by Complexation of mRNA Including a Secretion Sequence with PEG-based Block Catiomer.
    Curr Alzheimer Res. 2017;14:295-302.
    PubMed     Text format     Abstract available


  97. KNOCHEL C, Voss M, Gruter F, Alves GS, et al
    Omega-3 Fatty Acids: Repurposing Opportunities for Cognition and Biobehavioral Disturbances in MCI and Dementia.
    Curr Alzheimer Res. 2017;14:240-254.
    PubMed     Text format     Abstract available


  98. ZENG J, Li T, Gong M, Jiang W, et al
    Marginal Vitamin A Deficiency Exacerbates Memory Deficits Following Abeta1-42 Injection in Rats.
    Curr Alzheimer Res. 2017;14:562-570.
    PubMed     Text format     Abstract available


    December 2016
  99. BRUCKMANN S, Brenn A, Grube M, Niedrig K, et al
    Lack of P-glycoprotein Results in Impairment of Removal of Beta-Amyloid and Increased Intraparenchymal Cerebral Amyloid Angiopathy after Active Immunization in a Transgenic Mouse Model of Alzheimer's Disease.
    Curr Alzheimer Res. 2016.
    PubMed     Text format     Abstract available


  100. YU E, Liao Z, Mao D, Zhang Q, et al
    Directed functional connectivity of posterior cingulate cortex and whole brain in Alzheimer's disease and mild cognitive impairment.
    Curr Alzheimer Res. 2016.
    PubMed     Text format     Abstract available


  101. PU YZ, Liang L, Fu AL, Liu Y, et al
    Generation of Alzheimer's Disease Transgenic Zebrafish Expressing Human APP Mutation under Control of Zebrafish appb Promotor.
    Curr Alzheimer Res. 2016.
    PubMed     Text format     Abstract available


    November 2016
  102. MIRZA Z, Beg MA
    Molecular Interactions of Bexarotene - A Retinoid Drug And Alzheimer's Abeta Peptide: A Docking Study.
    Curr Alzheimer Res. 2016.
    PubMed     Text format     Abstract available


  103. ZHU R, Liu X, He Z
    Association of rs610932 and rs670139 Polymorphisms in the MS4A Gene Cluster with Alzheimer's Disease: An Updated Meta-analysis.
    Curr Alzheimer Res. 2016.
    PubMed     Text format     Abstract available


  104. ROUCH L, Cestac P, Cool C, Helmer C, et al
    Effectiveness of a standardized and specific follow-up in memory centers in patients with Alzheimer's disease.
    Curr Alzheimer Res. 2016.
    PubMed     Text format     Abstract available


  105. IVACHTCHENKO AV, Ivanenkov YA, Veselov MS
    Preclinical evaluation of AVN-322, novel and highly selective 5-HT6 receptor antagonist, for the treatment of Alzheimer's disease.
    Curr Alzheimer Res. 2016.
    PubMed     Text format     Abstract available


    October 2016
  106. SEIDL C, de Moraes Santos CA, De Simone A, Bartolini M, et al
    Uleine disrupts key enzymatic and non-enzymatic biomarkers that leads to Alzheimer's disease.
    Curr Alzheimer Res. 2016.
    PubMed     Text format     Abstract available


  107. XU DS, Ponce F
    Deep Brain Stimulation for Alzheimer's Disease.
    Curr Alzheimer Res. 2016.
    PubMed     Text format     Abstract available


  108. ZORZETTO M, Datturi F, Divizia L, Pistono C, et al
    Complement C4A and C4B gene copy number study in Alzheimer's disease patients.
    Curr Alzheimer Res. 2016.
    PubMed     Text format     Abstract available


  109. ARCE-VARAS N, Abate G, Prandelli C, Martinez C, et al
    Comparison of extracellular and intracellular blood compartments highlights redox alterations in Alzheimer's and Mild Cognitive Impairment patients.
    Curr Alzheimer Res. 2016.
    PubMed     Text format     Abstract available


  110. BOUTAJANGOUT A, Noorwali A, Atta H, Wisniewski T, et al
    Human Umbilical Cord Stem Cell Xenografts Improve Cognitive Decline and Reduce the Amyloid Burden in a Mouse Model of Alzheimer's Disease.
    Curr Alzheimer Res. 2016.
    PubMed     Text format     Abstract available


    September 2016
  111. DECOURT B, Lahiri DK, Sabbagh MN
    Targeting Tumor Necrosis Factor Alpha for Alzheimer's Disease.
    Curr Alzheimer Res. 2016.
    PubMed     Text format     Abstract available


  112. HSU D, Marshall GA
    Primary and Secondary Prevention Trials in Alzheimer Disease: Looking Back, Moving Forward.
    Curr Alzheimer Res. 2016.
    PubMed     Text format     Abstract available


  113. KAMKWALALA AR, Newhouse PA
    Beyond Acetylcholinesterase Inhibitors: Novel Cholinergic Treatments for Alzheimer's Disease.
    Curr Alzheimer Res. 2016.
    PubMed     Text format     Abstract available


  114. GONSALVEZ I, Baror R, Fried P, Santarnecchi E, et al
    Therapeutic Noninvasive Brain Stimulation in Alzheimer's Disease.
    Curr Alzheimer Res. 2016.
    PubMed     Text format     Abstract available


    August 2016

  115. Erratum: Therapeutic Approaches to Modulating Glutathione Levels as a Pharmacological Strategy in Alzheimer's Disease.
    Curr Alzheimer Res. 2016;13:1198.
    PubMed     Text format     Abstract available


  116. BUDNI J, Garcez ML, de Medeiros J, Cassaro E, et al
    The anti-inflammatory role of minocycline in Alzheimer s Disease.
    Curr Alzheimer Res. 2016.
    PubMed     Text format     Abstract available


  117. CYNA M, Lynch M, Oore JJ, Nagy PM, et al
    The benefits of exercise and metabolic interventions for the prevention and early treatment of Alzheimer's disease.
    Curr Alzheimer Res. 2016.
    PubMed     Text format     Abstract available


  118. VILLETTE V, Dutar P
    GABAergic microcircuits in Alzheimer's disease models.
    Curr Alzheimer Res. 2016.
    PubMed     Text format     Abstract available


  119. MA K, McLaurin J
    alpha-Melanocyte Stimulating Hormone as a Potential Therapy for Alzheimer's Disease.
    Curr Alzheimer Res. 2016.
    PubMed     Text format     Abstract available


  120. MONDRAGON-RODRIGUEZ S, Perry G, Pena-Ortega F, Williams S, et al
    Tau, Amyloid beta and Deep brain stimulation: Aiming to restore cognitive deficit in Alzheimer's disease.
    Curr Alzheimer Res. 2016.
    PubMed     Text format     Abstract available


  121. REED BT, Behar-Cohen F, Krantic S
    Seeing early signs of Alzheimer's Disease through the lens of the eye.
    Curr Alzheimer Res. 2016.
    PubMed     Text format     Abstract available


  122. CHATTERJEE P, Roy D
    Insight into the epigenetics of Alzheimer's disease: A computational study from human interactome.
    Curr Alzheimer Res. 2016.
    PubMed     Text format     Abstract available


    July 2016
  123. DOURADO MC, Laks J
    Psychological Interventions for Neuropsychiatric Disturbances in Mild and Moderate Alzheimer's Disease: Current Evidences and Future Directions.
    Curr Alzheimer Res. 2016.
    PubMed     Text format     Abstract available


  124. SERAFINI G, Calcagno P, Lester D, Girardi P, et al
    Suicide Risk in Alzheimer's Disease: A Systematic Review.
    Curr Alzheimer Res. 2016.
    PubMed     Text format     Abstract available


  125. LIAO Y, Qi XL, Cao Y, Yu WF, et al
    Elevations in the Levels of NF-kappaB and Inflammatory Chemotactic Factors in the Brains with Alzheimer's Disease - One Mechanism May Involve alpha3 Nicotinic Acetylcholine Receptor.
    Curr Alzheimer Res. 2016.
    PubMed     Text format     Abstract available


    June 2016
  126. TAKAHASHI R, Ishii K, Yokoyama K
    Validation of a New Imaging Technique Using the Glucose Metabolism to Amyloid Deposition Ratio in the Diagnosis of Alzheimer's Disease.
    Curr Alzheimer Res. 2016.
    PubMed     Text format     Abstract available


  127. CHIARAVALLOTI A, Danieli R, Lacanfora A, Palumbo B, et al
    Usefulness of 18F Florbetaben in diagnosis of Alzheimer's disease and other types of dementia.
    Curr Alzheimer Res. 2016.
    PubMed     Text format     Abstract available


  128. RUB U, Stratmann K, Heinsen H, Del Turco D, et al
    The brainstem tau cytoskeletal pathology of Alzheimer`s disease: A brief historical overview and description of its anatomical distribution pattern, evolutional features, pathogenetic and clinical relevance.
    Curr Alzheimer Res. 2016.
    PubMed     Text format     Abstract available


  129. ALVES GS, Carvalho AF, de Amorim de Carvalho L, Sudo FK, et al
    Neuroimaging findings related to behavioral disturbances in Alzheimer's disease: a systematic review.
    Curr Alzheimer Res. 2016.
    PubMed     Text format     Abstract available


  130. CHAKRABARTI SS, Bir A, Poddar J, Sinha M, et al
    Ceramide and sphingosine-1-phosphate in cell death pathways: Relevance to the pathogenesis of Alzheimer`s disease.
    Curr Alzheimer Res. 2016.
    PubMed     Text format     Abstract available


  131. WENZLERA S, Knochela C, Balabana C, Krafta D, et al
    Integrated biomarkers for depression in Alzheimer`s disease: a critical review.
    Curr Alzheimer Res. 2016.
    PubMed     Text format     Abstract available


  132. PEREIRA PA, Alvim-Soares A, Bicalho MA, de Moraes EN, et al
    Lack of association between genetic polymorphism of circadian genes (PER2, PER3, CLOCK and OX2R) with late onset depression and Alzheimer's disease in a sample of a Brazilian population (Circadian Genes, Late-Onset Depression and Alzheimer's Disease).
    Curr Alzheimer Res. 2016.
    PubMed     Text format     Abstract available


  133. FROST S, Guymer R, Aung KZ, Macaulay SL, et al
    Alzheimer`s disease and the early signs of age-related macular degeneration.
    Curr Alzheimer Res. 2016.
    PubMed     Text format     Abstract available


  134. KLIMOVA B, Kuca K
    Multi-Nutrient Dietary Intervention Approach to the Management of Alzheimer's Disease - A Mini-Review.
    Curr Alzheimer Res. 2016.
    PubMed     Text format     Abstract available


  135. TECCHIO F, Vecchio F, Ventriglia M, Porcaro C, et al
    Non-Ceruloplasmin Copper Appears a Disctinct Subtype of Alzheimer`s Disease: A Study of EEG-Derived Brain Activity.
    Curr Alzheimer Res. 2016.
    PubMed     Text format     Abstract available


  136. WANG J, Zhang X, Cheng X, Cheng J, et al
    LW-AFC, a herbal medicine for Alzheimer's disease, ameliorates cognitive deterioration and modulates neuroendocrine-immune system in senescence-accelerated mouse prone 8 strain.
    Curr Alzheimer Res. 2016.
    PubMed     Text format     Abstract available


  137. HEYMANN D, Stern Y, Cosentino S, Tatarina-Nulman O, et al
    The Association Between Alcohol Use and the Progression of Alzheimer's Disease.
    Curr Alzheimer Res. 2016.
    PubMed     Text format     Abstract available


    May 2016
  138. LIU CS, Ruthirakuhan M, Chau SA, Herrmann N, et al
    Pharmacological management of agitation and aggression in Alzheimer's Disease: a review of current and novel treatments.
    Curr Alzheimer Res. 2016.
    PubMed     Text format     Abstract available


  139. MATURA S, Carvalho AF, Alves GS, Pantel J, et al
    Physical exercise for the treatment of neuropsychiatric disturbances in Alzheimer's dementia: possible mechanisms, current evidence and future directions.
    Curr Alzheimer Res. 2016.
    PubMed     Text format     Abstract available


  140. VAN DAM D, Vermeiren Y, Dekker AD, Naude PJ, et al
    Neuropsychiatric disturbances in Alzheimer's disease: what have we learned from neuropathological studies?
    Curr Alzheimer Res. 2016.
    PubMed     Text format     Abstract available


    April 2016
  141. MAGISTRI M, Velmeshev D, Makhmutova M, Patel P, et al
    The BET-bromodomain inhibitor JQ1 reduces inflammation and tau phosphorylation at Ser396 in the brain of the 3xTg model of Alzheimer's disease.
    Curr Alzheimer Res. 2016.
    PubMed     Text format     Abstract available


  142. SALAS-GONZALEZ D, Segovia F, Martinez-Murcia FJ, Lang EW, et al
    An Optimal Approach for Selecting Discriminant Regions for the Diagnosis of Alzheimer's Disease.
    Curr Alzheimer Res. 2016.
    PubMed     Text format     Abstract available


  143. DARVESH S
    Butyrylcholinesterase as a Diagnostic and Therapeutic Target for Alzheimer's Disease.
    Curr Alzheimer Res. 2016.
    PubMed     Text format     Abstract available


  144. CINZIA S, Carla P, Pietro C
    Substance P and Alzheimer's disease: emerging novel roles.
    Curr Alzheimer Res. 2016.
    PubMed     Text format     Abstract available


  145. QIN L, Chong T, Rodriguez R, Pugazhenthi S, et al
    Glucagon-like peptide-1-mediated modulation of inflammatory pathways in the diabetic brain: Relevance to Alzheimer's disease.
    Curr Alzheimer Res. 2016.
    PubMed     Text format     Abstract available


  146. DIBATTISTA AM, Heinsinger NM, William Rebeck G
    Alzheimer's Disease Genetic Risk Factor APOE-epsilon4 Also Affects Normal Brain Function.
    Curr Alzheimer Res. 2016.
    PubMed     Text format     Abstract available


  147. ZHENG L, Duan J, Duan X, Zhou W, et al
    Association of Apolipoprotein E (ApoE) polymorphism with Alzheimer's Disease in Chinese population.
    Curr Alzheimer Res. 2016.
    PubMed     Text format     Abstract available


    March 2016
  148. FRINGS L, Spehl TS, Hull M, Meyer PT, et al
    Left Anterior Temporal Glucose Metabolism and not Amyloid-beta Load Predicts Naming Impairment in Alzheimer's Disease.
    Curr Alzheimer Res. 2016.
    PubMed     Text format     Abstract available


  149. JI L, Zhao X, Lu W, Zhang Q, et al
    Intracellular Abeta and its Pathological Role in Alzheimer's Disease: Lessons from Cellular to Animal Models.
    Curr Alzheimer Res. 2016.
    PubMed     Text format     Abstract available


  150. AL-BADDAI S, Neubauer A, Tome AM, Vigneron V, et al
    Functional Biomedical Images of Alzheimer's Disease a Green's Functionbased Empirical Mode Decomposition Study.
    Curr Alzheimer Res. 2016.
    PubMed     Text format     Abstract available


  151. FRANCOIS M, Fenech MF, Thomas P, Hor M, et al
    High content, multi-parameter analyses in buccal cells to identify Alzheimer's disease.
    Curr Alzheimer Res. 2016.
    PubMed     Text format     Abstract available


  152. VIGNERON V, Kodewitz A, Tomeb AM, Lelandais S, et al
    Alzheimer's disease brain areas: the machine learning support for blind localization.
    Curr Alzheimer Res. 2016.
    PubMed     Text format     Abstract available


  153. KRASHENYI I, Ramirez J, Popov A, Gorriz JM, et al
    Fuzzy Computer-Aided Alzheimer's Disease Diagnosis Based on MRI Data.
    Curr Alzheimer Res. 2016.
    PubMed     Text format     Abstract available


  154. MARTINEZ-MURCIAA FJ, Gorriza JM, Ramireza J, Ortizb For The Alzheimer's Disease Neuroimaging Initiative A, et al
    A Spherical Brain Mapping of MR Images for the Detection of Alzheimer's Disease.
    Curr Alzheimer Res. 2016.
    PubMed     Text format     Abstract available


  155. BALI P, Lahiri DK, Banik A, Nehru B, et al
    Potential for Stem Cells Therapy in Alzheimer's disease: Do neurotrophic factors play critical role?
    Curr Alzheimer Res. 2016.
    PubMed     Text format     Abstract available


  156. REGE SD, Geetha T, Broderick TL, Babu JR, et al
    Can Diet and Physical Activity limit Alzheimer's disease Risk?
    Curr Alzheimer Res. 2016.
    PubMed     Text format     Abstract available


  157. MCNAMARA J, Murray TA
    Connections between Herpes Simplex Virus Type 1 and Alzheimer's Disease Pathogenesis.
    Curr Alzheimer Res. 2016.
    PubMed     Text format     Abstract available


  158. DORSZEWSKA J, Prendecki M, Oczkowska A, Dezor M, et al
    Molecular basis of familial and sporadic Alzheimer's disease.
    Curr Alzheimer Res. 2016.
    PubMed     Text format     Abstract available


  159. LU W, Yang S, Zhang L, Chen L, et al
    Decreased Myelinated Fibers in the Hippocampal Dentate Gyrus of the Tg2576 Mouse Model of Alzheimer's Disease.
    Curr Alzheimer Res. 2016.
    PubMed     Text format     Abstract available


  160. FISAR Z, Hroudova J, Hansikova H, Spacilova J, et al
    Mitochondrial respiration in the platelets of patients with Alzheimer's disease.
    Curr Alzheimer Res. 2016.
    PubMed     Text format     Abstract available


  161. WEI W, Bodles-Brakhop AM, Barger SW
    A Role for P-Glycoprotein in Clearance of Alzheimer Amyloid beta-Peptide from the Brain.
    Curr Alzheimer Res. 2016.
    PubMed     Text format     Abstract available


    February 2016
  162. FERNANDEZ AP, Masa JS, Guedan MA, Futch HS, et al
    Adrenomedullin Expression in Alzheimer's Brain.
    Curr Alzheimer Res. 2016.
    PubMed     Text format     Abstract available


  163. RODRIGUEZ JJ, Butt AM, Gardenal E, Parpura V, et al
    Complex and differential glial responses in Alzheimer s disease and ageing.
    Curr Alzheimer Res. 2016.
    PubMed     Text format     Abstract available


  164. DJORDJEVIC J, Sabbir MG, Albensi BC
    Traumatic brain injury as a risk factor for Alzheimer's disease: Is inflammatory signaling a key player?
    Curr Alzheimer Res. 2016.
    PubMed     Text format     Abstract available


  165. GOLDECK D, Witkowski JM, Fulop T, Pawelec G, et al
    Peripheral immune signatures in Alzheimer Disease.
    Curr Alzheimer Res. 2016.
    PubMed     Text format     Abstract available


  166. MARNANE M, Hsiung GR
    Could better phenotyping small vessel disease provide new insights into Alzheimer Disease and improve clinical trial outcomes?
    Curr Alzheimer Res. 2016.
    PubMed     Text format     Abstract available


  167. MORRIS G, Berk M
    The Putative Use of Lithium in Alzheimer's Disease.
    Curr Alzheimer Res. 2016.
    PubMed     Text format     Abstract available


  168. SUGIMOTO T, Ono R, Murata S, Saji N, et al
    Prevalence and associated factors of sarcopenia in elderly subjects with amnestic mild cognitive impairment or Alzheimer disease.
    Curr Alzheimer Res. 2016.
    PubMed     Text format     Abstract available


    January 2016
  169. YANG KC, Chen HH
    Probabilistic cost-effectiveness analysis of vaccination for mild or moderate Alzheimer's disease.
    Curr Alzheimer Res. 2016.
    PubMed     Text format     Abstract available


  170. GONZALEZ-DOMINGUEZ R, Ruperez FJ, Garcia-Barrera T, Barbas C, et al
    METABOLOMIC-DRIVEN ELUCIDATION OF SERUM DISTURBANCES ASSOCIATED WITH ALZHEIMER S DISEASE AND MILD COGNITIVE IMPAIRMENT.
    Curr Alzheimer Res. 2016.
    PubMed     Text format     Abstract available


  171. TANG Z, Liu L, Li Y, Dong J, et al
    Urinary Metabolomics Reveals Alterations of Aromatic Amino Acid Metabolism of Alzheimer's Disease in the Transgenic CRND8 Mice.
    Curr Alzheimer Res. 2016.
    PubMed     Text format     Abstract available


  172. ZIYATDINOVA S, Ronnback A, Gurevicius K, Miszczuk D, et al
    Increased Epileptiform EEG Activity and Decreased Seizure Threshold in Arctic APP Transgenic Mouse Model of Alzheimer's Disease.
    Curr Alzheimer Res. 2016.
    PubMed     Text format     Abstract available


  173. COUNTS SE, He B, Prout JG, Michalski B, et al
    Cerebrospinal fluid proNGF: A putative biomarker for early Alzheimer's disease.
    Curr Alzheimer Res. 2016.
    PubMed     Text format     Abstract available


  174. DZAMBA D, Harantova L, Butenko O, Anderova M, et al
    Glial cells - the key elements of Alzheimer s disease.
    Curr Alzheimer Res. 2016.
    PubMed     Text format     Abstract available


  175. JI L, Zhao X, Lu W, Zhang Q, et al
    Intracellular Abeta and its pathological role in Alzheimer's disease: Lessons from cell and animal models.
    Curr Alzheimer Res. 2016.
    PubMed     Text format     Abstract available


  176. HEAD E, Lott IT, Wilcock DM, Lemere CA, et al
    Aging in Down Syndrome and the Development of Alzheimer's Disease Neuropathology.
    Curr Alzheimer Res. 2016;13:18-29.
    PubMed     Text format     Abstract available


  177. POTTER H, Granic A, Caneus J
    Role of Trisomy 21 Mosaicism in Sporadic and Familial Alzheimer's Disease.
    Curr Alzheimer Res. 2016;13:7-17.
    PubMed     Text format     Abstract available


  178. BARONE E
    Editorial: Oxidative Stress and Alzheimer Disease: Where Do We Stand?
    Curr Alzheimer Res. 2016;13:108-11.
    PubMed     Text format    


  179. CHEN Y, Yan H, Han Z, Bi Y, et al
    Functional Activity and Connectivity Differences of Five Resting-State Networks in Patients with Alzheimer's Disease or Mild Cognitive Impairment.
    Curr Alzheimer Res. 2016;13:234-42.
    PubMed     Text format     Abstract available


  180. MA J, Zhang W, Wang HF, Wang ZX, et al
    Peripheral Blood Adipokines and Insulin Levels in Patients with Alzheimer's Disease: A Replication Study and Meta-Analysis.
    Curr Alzheimer Res. 2016;13:223-33.
    PubMed     Text format     Abstract available


  181. HUANG Y, Lahiri DK
    Editorial: Translational Alzheimer's Disease Research.
    Curr Alzheimer Res. 2016;13:214.
    PubMed     Text format    


  182. WEINER MW, Gorriz JM, Ramirez J, Castiglioni I, et al
    Editorial: Statistical Signal Processing in the Analysis, Characterization and Detection of Alzheimer's Disease.
    Curr Alzheimer Res. 2016;13:466-8.
    PubMed     Text format    


  183. CHOI SS, Lee SR, Lee HJ
    Neurorestorative Role of Stem Cells in Alzheimer's Disease: Astrocyte Involvement.
    Curr Alzheimer Res. 2016;13:419-27.
    PubMed     Text format     Abstract available


  184. TOLEDANO A, Merino JJ, Rodriguez JJ
    Editorial: Neuroglia in Alzheimer's Disease: From Cohort to Contestant in the Disease Progression and its Therapy.
    Curr Alzheimer Res. 2016;13:318-20.
    PubMed     Text format    


  185. MAI S
    Editorial: Towards New Approaches in Alzheimer's Research and Alzheimer's Disease.
    Curr Alzheimer Res. 2016;13:728-9.
    PubMed     Text format    


  186. DI DOMENICO F, Pupo G, Giraldo E, Lloret A, et al
    Autoantibodies Profile in Matching CSF and Serum from AD and aMCI patients: Potential Pathogenic Role and Link to Oxidative Damage.
    Curr Alzheimer Res. 2016;13:112-22.
    PubMed     Text format     Abstract available


  187. CUI YQ, Wang Q, Zhang DM, Wang JY, et al
    Triptolide Rescues Spatial Memory Deficits and Amyloid-beta Aggregation Accompanied by Inhibition of Inflammatory Responses and MAPKs Activity in APP/PS1 Transgenic Mice.
    Curr Alzheimer Res. 2016;13:288-96.
    PubMed     Text format     Abstract available


  188. POLJAK A, Crawford JD, Smythe GA, Brodaty H, et al
    The Relationship Between Plasma Abeta Levels, Cognitive Function and Brain Volumetrics: Sydney Memory and Ageing Study.
    Curr Alzheimer Res. 2016;13:243-55.
    PubMed     Text format     Abstract available


  189. RIVERA A, Vanzuli I, Arellano JJ, Butt A, et al
    Decreased Regenerative Capacity of Oligodendrocyte Progenitor Cells (NG2-Glia) in the Ageing Brain: A Vicious Cycle of Synaptic Dysfunction, Myelin Loss and Neuronal Disruption?
    Curr Alzheimer Res. 2016;13:413-8.
    PubMed     Text format     Abstract available


  190. HOGENAUER M, Brendel M, Delker A, Darr S, et al
    Impact of MRI-based Segmentation Artifacts on Amyloid- and FDG-PET Quantitation.
    Curr Alzheimer Res. 2016;13:597-607.
    PubMed     Text format     Abstract available


  191. BRENDEL M, Reinisch V, Kalinowski E, Levin J, et al
    Hypometabolism in Brain of Cognitively Normal Patients with Depressive Symptoms is Accompanied by Atrophy-Related Partial Volume Effects.
    Curr Alzheimer Res. 2016;13:475-86.
    PubMed     Text format     Abstract available


  192. VASTA R, Augimeri A, Cerasa A, Nigro S, et al
    Hippocampal Subfield Atrophies in Converted and Not-Converted Mild Cognitive Impairments Patients by a Markov Random Fields Algorithm.
    Curr Alzheimer Res. 2016;13:566-74.
    PubMed     Text format     Abstract available


  193. WILKE C, Gillardon F, Deuschle C, Dubois E, et al
    Serum Levels of Progranulin Do Not Reflect Cerebrospinal Fluid Levels in Neurodegenerative Disease.
    Curr Alzheimer Res. 2016;13:654-62.
    PubMed     Text format     Abstract available


  194. IRWIN JA, Erisir A, Kwon I
    Oral Triphenylmethane Food Dye Analog, Brilliant Blue G, Prevents Neuronal Loss in APPSwDI/NOS2-/- Mouse Model.
    Curr Alzheimer Res. 2016;13:663-77.
    PubMed     Text format     Abstract available


  195. MA C, Zhang Y, Li X, Chen Y, et al
    The TT allele of rs405509 synergizes with APOE epsilon4 in the impairment of cognition and its underlying default mode network in non-demented elderly.
    Curr Alzheimer Res. 2016;13:708-17.
    PubMed     Text format     Abstract available


  196. SALVATORE C, Battista P, Castiglioni I
    Frontiers for the Early Diagnosis of AD by Means of MRI Brain Imaging and Support Vector Machines.
    Curr Alzheimer Res. 2016;13:509-33.
    PubMed     Text format     Abstract available


  197. GALLIVANONE F, Della Rosa PA, Castiglioni I
    Statistical Voxel-Based Methods and [18F]FDG PET Brain Imaging: Frontiers for the Diagnosis of AD.
    Curr Alzheimer Res. 2016;13:682-94.
    PubMed     Text format     Abstract available


    December 2015
  198. BECK JS, Mufson EJ, Counts SE
    Evidence for mitochondrial UPR gene activation in familial and sporadic Alzheimer's disease.
    Curr Alzheimer Res. 2015.
    PubMed     Text format     Abstract available


  199. XU J, Xia LL, Song N, Chen SD, et al
    Testosterone, Estradiol, and Sex Hormone-Binding Globulin in Alzheimer's Disease: A Meta-Analysis.
    Curr Alzheimer Res. 2015.
    PubMed     Text format     Abstract available


  200. VICKERS JC, Woodhouse A, Fernandez-Martos CM, Kirkcaldie MT, et al
    Defining the earliest pathological changes of Alzheimer's disease.
    Curr Alzheimer Res. 2015.
    PubMed     Text format     Abstract available


  201. BU XL, Jiao SS, Lian Y, Wang YJ, et al
    Perspectives on the tertiary prevention strategy for Alzheimer's disease.
    Curr Alzheimer Res. 2015.
    PubMed     Text format     Abstract available


    November 2015
  202. ESTERAS N, Alquezar C, de la Encarnacion A, Martin-Requero A, et al
    Lymphocytes in Alzheimer's disease pathology: Altered signaling pathways.
    Curr Alzheimer Res. 2015.
    PubMed     Text format     Abstract available


  203. TEJERA D, Heneka MT
    Microglia in Alzheimer's disease: the good, the bad and the ugly.
    Curr Alzheimer Res. 2015.
    PubMed     Text format     Abstract available


  204. BERGERON D, Bensaidane R, Laforce R Jr
    Untangling Alzheimer's disease clinicoanatomical heterogeneity through selective network vulnerability - an effort to understand a complex disease.
    Curr Alzheimer Res. 2015.
    PubMed     Text format     Abstract available


  205. BESGA-BASTERRA A, Chyzhyk D, Gonzalez-Ortega I, Savio A, et al
    Eigenanatomy on fractional anisotropy imaging provides white matter anatomical features discriminating between Alzheimer's Disease and Late Onset Bipolar Disorder.
    Curr Alzheimer Res. 2015.
    PubMed     Text format     Abstract available


  206. MERINO JJ, Muneton-Gomez V, Alvarez MI, Toledano-Diaz A, et al
    Effects of CX3CR1 and fractalkine chemokines in amyloid beta clearance and p-Tau accumulation in Alzheimer,s disease (AD) rodent models: Is fractalkine a systemic biomarker for AD?
    Curr Alzheimer Res. 2015.
    PubMed     Text format     Abstract available


  207. LIM D, Rodriguez-Arellano JJ, Parpura V, Zorec R, et al
    Calcium signalling toolkits in astrocytes and spatio-temporal progression of Alzheimer's disease.
    Curr Alzheimer Res. 2015.
    PubMed     Text format     Abstract available


  208. CARMONA P, Molina M, Toledano A
    Blood-based biomarkers of Alzheimer s disease: diagnostic algorithms and new technologies.
    Curr Alzheimer Res. 2015.
    PubMed     Text format     Abstract available


  209. TOLEDANO A, Alvarez MI, Toledano-Diaz A, Merino JJ, et al
    Brain local and regional neuroglial alterations in Alzheimer s Disease: cell types, responses and implications.
    Curr Alzheimer Res. 2015.
    PubMed     Text format     Abstract available


  210. SU L, Blamire AM, Watson R, He J, et al
    Cortical and subcortical changes in Alzheimer's disease: a longitudinal and quantitative MRI study.
    Curr Alzheimer Res. 2015.
    PubMed     Text format     Abstract available


  211. SEGOVIA F, G'orriz JM, Ram'irez J, Phillips C, et al
    Combining feature extraction methods to assist the diagnosis of Alzheimer's disease.
    Curr Alzheimer Res. 2015.
    PubMed     Text format     Abstract available


  212. MARTINEZ-MURCIA FJ, Gorriz JM, Ramirez J, Ortiz A, et al
    A Statistical Projection of MRI Brain Images for the Detection of Alzheimer's Disease.
    Curr Alzheimer Res. 2015.
    PubMed     Text format     Abstract available


  213. ZIPPO AG, Castiglioni I
    Integration of 18FDG-PET Metabolic and Functional Connectomes in the Early Diagnosis and Prognosis of the Alzheimer's Disease.
    Curr Alzheimer Res. 2015.
    PubMed     Text format     Abstract available


    October 2015
  214. HERRAN E, Perez-Gonzalez R, Igartua M, Pedraz JL, et al
    Enhanced hippocampal neurogenesis in APP/Ps1 mouse model of Alzheimer's disease after implantation of VEGF-loaded PLGA nanospheres.
    Curr Alzheimer Res. 2015.
    PubMed     Text format     Abstract available


  215. KARA F, Hofling C, Rossner S, Schliebs R, et al
    In vivo longitudinal monitoring of changes in the corpus callosum integrity during disease progression in a mouse model of Alzheimer's disease.
    Curr Alzheimer Res. 2015.
    PubMed     Text format     Abstract available


  216. RASMUSSEN L, Delabio R, Viani GA, Chen E, et al
    Differential Expression of Ribosomal Genes in Brain and Blood of Alzheimer's Disease Patients.
    Curr Alzheimer Res. 2015.
    PubMed     Text format     Abstract available


  217. ZIVKOVIC L, Bajic V, Perry G, Spremo-Potparevica B, et al
    Alterations of the X Chromosome in Lymphocytes of Alzheimer's Disease Patients.
    Curr Alzheimer Res. 2015.
    PubMed     Text format     Abstract available


  218. LIN TW, Liu YF, Shih HS, Chen SJ, et al
    Neurodegeneration in amygdala precedes hippocampus in the APPswe/PS1dE9 mouse model of Alzheimer's disease.
    Curr Alzheimer Res. 2015.
    PubMed     Text format     Abstract available


  219. WIESMANN M, Capone C, Zerbi V, Mellendijk L, et al
    Hypertension impairs cerebral blood flow in a mouse model for Alzheimer's disease.
    Curr Alzheimer Res. 2015.
    PubMed     Text format     Abstract available


  220. BOIOCCHI C, Maggioli E, Monti MC, Zorzetto M, et al
    The Possible Involved of HLA Class III Haplotype (RAGE, HSP70 and TNF Genes) in Alzheimer's Disease.
    Curr Alzheimer Res. 2015.
    PubMed     Text format     Abstract available


  221. SALEHI A, Ashford JW, Mufson EJ
    Editorial: The Link between Alzheimer's Disease and Down Syndrome. A Historical Perspective.
    Curr Alzheimer Res. 2015.
    PubMed     Text format    


    September 2015
  222. HAMLETT E, Boger HA, Ledreux A, Kelley CM, et al
    Cognitive Impairment, Neuroimaging, and Alzheimer Neuropathology in Mouse Models of Down Syndrome.
    Curr Alzheimer Res. 2015.
    PubMed     Text format     Abstract available


  223. PHILLIPS C, Fahimi A, Das D, Mojabi FS, et al
    Noradrenergic System in Down Syndrome and Alzheimer's Disease A Target for Therapy.
    Curr Alzheimer Res. 2015.
    PubMed     Text format     Abstract available


  224. IULITA MF, Claudio Cuello CA
    The NGF Metabolic Pathway in the CNS and its Dysregulation in Down Syndrome and Alzheimer's disease.
    Curr Alzheimer Res. 2015.
    PubMed     Text format     Abstract available


  225. STRUPP BJ, Powers BE, Velazquez R, Ash JA, et al
    Maternal choline supplementation:A potential prenatal treatment for Down syndrome and Alzheimer's disease.
    Curr Alzheimer Res. 2015.
    PubMed     Text format     Abstract available


  226. SERINI S, Calviello G
    Reduction of oxidative/nitrosative stress in brain and its involvement in the neuroprotective effect of n-3 PUFA in Alzheimer's disease.
    Curr Alzheimer Res. 2015.
    PubMed     Text format     Abstract available


  227. LLORET A, Fuchsberger T, Giraldo E, Vina J, et al
    Reductive stress: A new concept in Alzheimer's disease.
    Curr Alzheimer Res. 2015.
    PubMed     Text format     Abstract available


  228. GIUDETTI AM, Romano A, Lavecchia AM, Gaetani S, et al
    The role of brain cholesterol and its oxidized products in Alzheimer's disease.
    Curr Alzheimer Res. 2015.
    PubMed     Text format     Abstract available


    July 2015
  229. COUPLAND KG, Kim WS, Halliday GM, Hallupp M, et al
    Effect of PSEN1 mutations on MAPT methylation in early-onset Alzheimer's disease.
    Curr Alzheimer Res. 2015.
    PubMed     Text format     Abstract available


  230. INEKCI D, Henriksen K, Linemann T, Karsdal MA, et al
    Serum fragments of Tau for the differential diagnosis of Alzheimer's disease.
    Curr Alzheimer Res. 2015.
    PubMed     Text format     Abstract available


  231. BEAUCHET O, Cp L, Montero-Odasso M, Annweiler C, et al
    Anti-dementia drugs-related changes in gait performance while single and dual tasking in patients with Alzheimer disease: a meta-analysis.
    Curr Alzheimer Res. 2015.
    PubMed     Text format     Abstract available


  232. SUI X, Zhu M, Cui Y, Yu C, et al
    Functional connectivity hubs could serve as a potential biomarker in Alzheimer's disease: a reproducible study.
    Curr Alzheimer Res. 2015.
    PubMed     Text format     Abstract available


  233. CHENG XR, Cui XL, Zheng Y, Zhang GR, et al
    A co-module regulated by therapeutic drugs in a molecular subnetwork of Alzheimer's disease identified on the basis of traditional Chinese medicine and SAMP8 mice.
    Curr Alzheimer Res. 2015.
    PubMed     Text format     Abstract available


  234. EL HAJ M, Raffard S, Antoine P, Gely-Nargeot MC, et al
    Emotion and destination memory in Alzheimer's Disease.
    Curr Alzheimer Res. 2015.
    PubMed     Text format     Abstract available


  235. PLAGG B, Ehrlich D, Kniewallner KM, Marksteiner J, et al
    Increased acetylation of histone H4 at lysine 12 (H4K12) in monocytes of transgenic Alzheimer's mice and in human patients.
    Curr Alzheimer Res. 2015.
    PubMed     Text format     Abstract available


  236. FERRARI R, Ferrara M, Alinani A, Sutton RB, et al
    Screening of Early and Late Onset Alzheimer's Disease Genetic Risk Factors in a Cohort of Dementia Patients from Liguria, Italy.
    Curr Alzheimer Res. 2015.
    PubMed     Text format     Abstract available


  237. NUZZO D, Picone P, Baldassano S, Caruana L, et al
    Insulin Resistance as Common Molecular Denominator Linking Obesity to Alzheimer's Disease.
    Curr Alzheimer Res. 2015.
    PubMed     Text format     Abstract available


  238. ZHANG Y, Wang F, Luo X, Wang L, et al
    Cognitive improvement by photic stimulation in a mouse model of Alzheimer's disease.
    Curr Alzheimer Res. 2015.
    PubMed     Text format     Abstract available


  239. VOLGYI K, Juhasz G, Kovacs Z, Penke B, et al
    Dysfunction of Endoplasmic Reticulum (ER) and Mitochondria (MT) in Alzheimer's Disease: The Role of the ER-MT Cross-Talk.
    Curr Alzheimer Res. 2015.
    PubMed     Text format     Abstract available


  240. WALDRON A, Wyffels L, Verhaeghe J, Bottelbergs A, et al
    Quantitative muPET Imaging of Cerebral Glucose Metabolism and Amyloidosis in the TASTPM Double Transgenic Mouse Model of Alzheimer's Disease.
    Curr Alzheimer Res. 2015.
    PubMed     Text format     Abstract available


  241. YASUE M, Sugiura S, Uchida Y, Otake H, et al
    Prevalence of Sinusitis Detected by Magnetic Resonance Imaging in Subjects with Dementia or Alzheimer's Disease.
    Curr Alzheimer Res. 2015.
    PubMed     Text format     Abstract available


    May 2015
  242. CM K, Jh W, Jm L, Jh R, et al
    Amyloid Beta-Weighted Cortical Thickness: A New Imaging Biomarker in Alzheimer's Disease.
    Curr Alzheimer Res. 2015.
    PubMed     Text format     Abstract available


  243. Q Z, Q G, X L, M C, et al
    Auditory Verbal Learning Test is Superior to Rey-Osterrieth Complex Figure Memory for Predicting Mild Cognitive Impairment to Alzheimer's disease.
    Curr Alzheimer Res. 2015.
    PubMed     Text format     Abstract available


  244. B Z
    Prevention strategies targeting different preclinical stages of Alzheimer's disease.
    Curr Alzheimer Res. 2015.
    PubMed     Text format     Abstract available


    January 2015
  245. JEONG YJ, Kang GY, Kwon JH, Choi HD, et al
    1950 MHz Electromagnetic Fields Ameliorate Abeta Pathology in Alzheimer's Disease Mice.
    Curr Alzheimer Res. 2015;12:481-92.
    PubMed     Text format     Abstract available


  246. DEZSI L, Tuka B, Martos D, Vecsei L, et al
    Alzheimer's disease, astrocytes and kynurenines.
    Curr Alzheimer Res. 2015;12:462-80.
    PubMed     Text format     Abstract available


  247. MA DL, Leung CH
    Editorial: small molecule therapeutics for Alzheimer's disease.
    Curr Alzheimer Res. 2015;12:400-2.
    PubMed     Text format    


  248. RASKIN J, Cummings J, Hardy J, Schuh K, et al
    Neurobiology of Alzheimer's Disease: Integrated Molecular, Physiological, Anatomical, Biomarker, and Cognitive Dimensions.
    Curr Alzheimer Res. 2015;12:712-22.
    PubMed     Text format     Abstract available


  249. MARESOVA P, Mohelska H, Dolejs J, Kuca K, et al
    Socio-economic Aspects of Alzheimer's Disease.
    Curr Alzheimer Res. 2015;12:903-11.
    PubMed     Text format     Abstract available


  250. LAHIRI DK
    View of excellent ROAD from the CAR.
    Curr Alzheimer Res. 2015;12:96-9.
    PubMed     Text format    


  251. ZHANG Y, Zou J, Yang J, Yao Z, et al
    4Abeta1-15-Derived Monoclonal Antibody Reduces More Abeta Burdens and Neuroinflammation than Homologous Vaccine in APP/PS1 Mice.
    Curr Alzheimer Res. 2015;12:384-97.
    PubMed     Text format     Abstract available


  252. CHAO F, Zhang L, Luo Y, Xiao Q, et al
    Running Exercise Reduces Myelinated Fiber Loss in the Dentate Gyrus of the Hippocampus in APP/PS1 Transgenic Mice.
    Curr Alzheimer Res. 2015;12:377-83.
    PubMed     Text format     Abstract available


  253. ANTES R, Salomon-Zimri S, Beck SC, Garcia Garrido M, et al
    VEGF Mediates ApoE4-Induced Neovascularization and Synaptic Pathology in the Choroid and Retina.
    Curr Alzheimer Res. 2015;12:323-34.
    PubMed     Text format     Abstract available


  254. DEACON RM, Altimiras FJ, Bazan-Leon EA, Pyarasani RD, et al
    Natural AD-Like Neuropathology in Octodon degus: Impaired Burrowing and Neuroinflammation.
    Curr Alzheimer Res. 2015;12:314-22.
    PubMed     Text format     Abstract available


  255. WONG CY, Chung LH, Lu L, Wang M, et al
    Dual Inhibition And Monitoring Of Beta-amyloid Fibrillation By A Luminescent Iridium(III) Complex.
    Curr Alzheimer Res. 2015;12:439-44.
    PubMed     Text format     Abstract available


  256. KOCHI A, Lee HJ, Vithanarachchi SM, Padmini V, et al
    Inhibitory Activity Of Curcumin Derivatives Towards Metal-free And Metal-induced Amyloid-beta Aggregation.
    Curr Alzheimer Res. 2015;12:415-23.
    PubMed     Text format     Abstract available


    January 2014
  257. ALBERT M, Soldan A, Gottesman R, McKhann G, et al
    Cognitive changes preceding clinical symptom onset of mild cognitive impairment and relationship to ApoE genotype.
    Curr Alzheimer Res. 2014;11:773-84.
    PubMed     Text format     Abstract available


  258. WAKEFIELD SJ, McGeown WJ, Shanks MF, Venneri A, et al
    Differentiating normal from pathological brain ageing using standard neuropsychological tests.
    Curr Alzheimer Res. 2014;11:765-72.
    PubMed     Text format     Abstract available


  259. WANG J, Zhang Y, Xu H, Zhu S, et al
    Fluoxetine improves behavioral performance by suppressing the production of soluble beta-amyloid in APP/PS1 mice.
    Curr Alzheimer Res. 2014;11:672-80.
    PubMed     Text format     Abstract available


  260. IYER AM, van Scheppingen J, Milenkovic I, Anink JJ, et al
    Metabotropic glutamate receptor 5 in Down's syndrome hippocampus during development: increased expression in astrocytes.
    Curr Alzheimer Res. 2014;11:694-705.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Alzheimer's Disease is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: